These results are consistent with observed reductions in AVP release associated with Gi DREADD inhibition of the MnPO during ANG II or 3% HTN exposure, with ANG II inducing a greater release of AVP than 3% HTN between groups. Here, AVP is linked to hypertensive disorder.